DiaMedica Therapeutics (DMAC) Capital Leases (2018 - 2026)

DiaMedica Therapeutics' (DMAC) quarterly Capital Leases came in at $1000.0 in Q1 2026, down 90.0% year-on-year from $10000.0 in Q1 2025, and down 75.0% quarter-over-quarter from $4000.0 in Q4 2025.

DiaMedica Therapeutics (DMAC) Capital Leases (2018 - 2026) Analysis & Trends

DiaMedica Therapeutics' Capital Leases history runs 9 years deep, the most recent figure standing at $1000.0 for Q1 2026.

  • On a quarterly basis, Capital Leases fell 90.0% year-over-year to $1000.0 in Q1 2026; TTM through Mar 2026 was $1000.0, a 90.0% decrease from a year earlier, with the FY2025 full-year figure at $4000.0, down 66.67% from the prior year.
  • Capital Leases fell to $1000.0 in Q1 2026 per DMAC's latest filing, from $4000.0 in the prior quarter.
  • Across five years, Capital Leases topped out at $377000.0 in Q1 2023 and bottomed at $1000.0 in Q4 2023.
  • The 5-year median for Capital Leases is $7500.0 (2022), against an average of $52187.5.
  • Across the five-year window, Capital Leases surged 5000.0% in 2023 and tumbled 95.52% in 2024, its largest moves.
  • Year by year, Capital Leases stood at $4000.0 in 2022, then sank by 75.0% to $1000.0 in 2023, then jumped by 1100.0% to $12000.0 in 2024, then sank by 66.67% to $4000.0 in 2025, then sank by 75.0% to $1000.0 in 2026.
  • Per Business Quant, the three latest DMAC Capital Leases figures stand at $1000.0 (Q1 2026), $4000.0 (Q4 2025), and $7000.0 (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn -
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn -
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn
7 Belite Bio 61.40 Bn 61.40 Bn -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn
9 Revolution Medicines 37.37 Bn 37.37 Bn -
10 DiaMedica Therapeutics 364.72 Mn 364.72 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 1,000.00
Dec 31, 2025 4,000.00
Sep 30, 2025 7,000.00
Jun 30, 2025 8,000.00
Mar 31, 2025 10,000.00
Dec 31, 2024 12,000.00
Sep 30, 2024 14,000.00
Jun 30, 2024 16,000.00
Dec 31, 2023 1,000.00
Sep 30, 2023 3,000.00
Jun 30, 2023 357,000.00
Mar 31, 2023 377,000.00
Dec 31, 2022 4,000.00
Sep 30, 2022 5,000.00
Jun 30, 2022 7,000.00
Mar 31, 2022 9,000.00
Sep 30, 2021 4,000.00
Jun 30, 2021 5,000.00
Mar 31, 2021 5,000.00
Dec 31, 2020 7,000.00